Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases
Authors
Katja Goricar
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Viljem Kovac
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Metoda Dodic-Fikfak
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Vita Dolzan
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Alenka Franko
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 86 - 95
Published on: Mar 7, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Katja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, Vita Dolzan, Alenka Franko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.